🚀 VIALASE IS READY TO SOAR AT AAO 2024 IN CHICAGO! Join us at Eyecelerator as we unveil new details on our pioneering, incision-free FLIGHT procedure with our game-changing, femtosecond laser technology. Don’t miss the opportunity to hear from our very own Chief Medical Officer, Richard Lewis MD, as he shares how ViaLase is shaping the future of glaucoma care. Learn more at vialase.com and register for Eyecelerator @ AAO 2024 at https://bit.ly/4eCUKfP.
About us
ViaLase, Inc. is an ophthalmic med-tech, venture capital backed company located in Aliso Viejo, CA. ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment to enhance glaucoma patient care. The ViaLase team has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for Ophthalmic surgery for the refractive patient and cataract patient; and now bringing that expertise to the glaucoma patient. ViaLase® products are currently not for sale, pending regulatory clearance.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Aliso Viejo, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
95 Enterprise
Suite 100
Aliso Viejo, CA 92656, US
Employees at ViaLase, Inc
Updates
-
The current glaucoma treatment landscape is ripe for disruption... In a recent Ocular Surgery News article, John Hovanesian, MD, FACS, explains why he believes ViaLase's pioneering technology can potentially address a major unmet need in glaucoma. Thanks to Healio | Ocular Surgery News for the feature! Read the full article here: https://bit.ly/3WN2AMa
-
-
Yes, it's real... ViaLase is revealing a new era of incision-free glaucoma treatment. Our pioneering femtosecond laser-based technology will soon bring a new level of imaging and precision to glaucoma care. See for yourself at seeingisbelieving.us
-
We had an action-packed few days in Barcelona, where we showcased ViaLase’s pioneering femtosecond laser technology throughout the show. A heartfelt thank you to our esteemed advisory board members, including Professor H. Burkhard Dick and Professor Zoltan Nagy, for their outstanding presentations. Couldn't join us at ESCRS? Discover more about our cutting-edge, incision-free glaucoma treatment at seeingisbelieving.us!
Learn more about our cutting-edge, incision-free glaucoma treatment!
-
Rick Lewis, MD, Chief Medical Officer of ViaLase, proudly took to the stage at the The European Society of Cataract and Refractive Surgeons (ESCRS) iNovation Day to share his perspective on our pioneering technology that’s set to change the glaucoma game. Read the @CAKE Magazine spotlight article here: https://lnkd.in/gqqG7ATt
-
-
🚀 What a way to kick off ESCRS! 🚀 Thank you, Sheraz Daya, as well as the rest of our distinguished advisory board for your invaluable support in paving the way for our European commercial launch! Ike Ahmed Gus Gazzard Karsten Klabe Elena Arrondo Ticiana De Francesco Robert Ang Paz Orts Zoltan Z Nagy Burkhard Dick #ophthalmology #medtech #glaucoma
What a bunch of powerful ophthalmologists- feel like an #imposter ! ViaLase, Inc The future is “FLIGHT” watch this space !
-
-
ViaLase is ready to take FLigHT at the upcoming 2024 ESCRS Congress! Join ViaLase's Chief Commercial Officer, Shawn O'Neil, at Ophthalmology Futures European Forum on September 5 immediately before ESCRS. On September 6, head to ESCRS iNovation Day to hear from ViaLase's Chief Medical Officer, Rick Lewis, MD. And don’t miss H. Burkhard Dick, MD, PhD, speak on September 7 at Teleon 's booth. Later that evening, be sure to check out Professor Zoltan Nagy's E-Poster Presentation. At these upcoming sessions, we'll be discussing how ViaLase's pioneering femtosecond laser technology will shape the future of ophthalmology in Europe and beyond. For full event details, see the registration links below. Register for Ophthalmology Futures: https://bit.ly/3T9vbKy Register for ESCRS: https://bit.ly/4cJU0Uj
-
Did you miss our symposium at this year's European Glaucoma Society congress? In the most recent issue of Cataract & Refractive Surgery Today Global, thought leaders Elena Arrondo, MD, Marta Ibarz Barberá, MD, PhD, Karsten Klabe, MD, and Andrew Tatham, MD share how ViaLase’s femtosecond laser image-guided, high-precision trabeculotomy (FLIGHT) is fueling the practice of noninvasive interventional glaucoma. Read the article here: https://bit.ly/4cty93m
-
-
We’re so grateful for your advocacy and share your enthusiasm Professor Burkhard Dick! The potential impact this technology may have on glaucoma patient care is truly encouraging. #ophthalmology #medicaltechnology #glaucoma
Did you hear the news? The ViaLase Laser has been granted CE Mark certification! We're not done celebrating this milestone and extend our heartfelt gratitude to all our advisory board members for their invaluable support throughout this journey. Join us as several esteemed members of our advisory board share their congratulations and insights on the significance of this achievement. Watch to learn more and see the press release at https://lnkd.in/etXC6V5c Burkhard Dick Ike Ahmed Gus Gazzard Zoltan Z Nagy Ticiana De Francesco John Berdahl Sheybani Arsham Lorraine Provencher William Wiley Nathan Radcliffe
The ViaLase Laser has been granted CE Mark certification!
-
Did you hear the news? The ViaLase Laser has been granted CE Mark certification! We're not done celebrating this milestone and extend our heartfelt gratitude to all our advisory board members for their invaluable support throughout this journey. Join us as several esteemed members of our advisory board share their congratulations and insights on the significance of this achievement. Watch to learn more and see the press release at https://lnkd.in/etXC6V5c Burkhard Dick Ike Ahmed Gus Gazzard Zoltan Z Nagy Ticiana De Francesco John Berdahl Sheybani Arsham Lorraine Provencher William Wiley Nathan Radcliffe
The ViaLase Laser has been granted CE Mark certification!